Publication | Open Access
Observations on the systemic effect of topical clobetasol propionate (Dermovate).
111
Citations
8
References
1975
Year
Adrenal GlandClobetasol PropionateDiseased SkinMedicineDiabetesTopical DrugClinical DermatologySkin PharmacologySystemic EffectWound HealingNormal PeopleDermatologyAdrenal DiseaseEndocrinologyPharmacologyExperimental Dermatology
Topical application of clobetasol propionate in a strength of 0-05% in cream or ointment (Dermovate) suppressed the hypothalamic-pituitary-adrenal axis in both normal people and patients with diseased skin. In normal people the 9 am serum cortisol level was suppressed when between 45 and 90 g was applied weekly. Insulin stress test results in patients with diseased skin showed an abnormally small response after long-term application of similar amounts. We conclude that long-term administration should be restricted to less than 50 g a week.
| Year | Citations | |
|---|---|---|
Page 1
Page 1